Ballentine Partners LLC Purchases 434 Shares of Colgate-Palmolive (NYSE:CL)

Ballentine Partners LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,336 shares of the company’s stock after purchasing an additional 434 shares during the quarter. Ballentine Partners LLC’s holdings in Colgate-Palmolive were worth $841,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Regal Investment Advisors LLC grew its stake in shares of Colgate-Palmolive by 1.6% during the 4th quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock worth $604,000 after purchasing an additional 121 shares during the period. M&G Investment Management Ltd. boosted its holdings in shares of Colgate-Palmolive by 0.3% during the 4th quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after purchasing an additional 125 shares during the last quarter. Wealthcare Advisory Partners LLC increased its holdings in shares of Colgate-Palmolive by 3.9% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 3,404 shares of the company’s stock valued at $271,000 after purchasing an additional 127 shares during the last quarter. &PARTNERS raised its holdings in shares of Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after acquiring an additional 129 shares during the period. Finally, AMG National Trust Bank grew its stake in shares of Colgate-Palmolive by 0.4% in the 4th quarter. AMG National Trust Bank now owns 30,232 shares of the company’s stock valued at $2,410,000 after buying an additional 131 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock traded up $0.30 during midday trading on Monday, hitting $97.57. 194,393 shares of the stock were exchanged, compared to its average volume of 4,417,573. The stock has a market cap of $80.05 billion, a price-to-earnings ratio of 30.78, a PEG ratio of 3.57 and a beta of 0.39. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $98.00. The stock’s 50-day moving average price is $92.71 and its 200-day moving average price is $86.92.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.73 earnings per share. Research analysts predict that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.05%. The ex-dividend date is Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CL shares. Argus increased their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Stifel Nicolaus increased their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a report on Monday, April 29th. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 price objective for the company. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 28th. Finally, Bank of America boosted their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $93.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.